[ad_1] Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported…
diagnostic
-
-
STOCK MARKET
Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 17% to a record high on Thursday, after the…
-
STOCK MARKET
Elon Musk says Neuralink has implanted brain chip into a human for first time
by userby user[ad_1] Elon Musk said Monday that his company Neuralink has conducted its first brain implant…
-
STOCK MARKET
Bayer shares slump after jury awards $2.25 billion over Monsanto weedkiller lawsuit
by userby user[ad_1] Shares in Bayer fell 5% on Monday after a Philadelphia jury told the German…
-
STOCK MARKET
Philips to halt CPAP sales in the U.S. as it takes $393 million provision
by userby user[ad_1] Philips on Monday said it will halt the sales of new sleep-therapy devices in…
-
STOCK MARKET
How government meddling could end a golden age for life-changing new drugs
by userby user[ad_1] We’re in a golden age of medical discovery. Consider just a handful of new…
-
[ad_1] General Electric Co. has saved its best year for its last. At the beginning…
-
STOCK MARKET
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?
by userby user[ad_1] The obesity drugs that powered huge investor gains in 2023 are poised to inspire…
-
STOCK MARKET
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
by userby user[ad_1] Vertex Pharmaceuticals Inc. shares VRTX, +11.10% were on track for an all-time high Wednesday…
-
STOCK MARKET
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
by userby user[ad_1] Crispr Therapeutics AG CRSP, -5.33% and Vertex Pharmaceuticals Inc. VRTX, -0.82% on Friday got…